Studies on cyclic adenosine 3' ,5'-monophosphate levels, Adenylate cyclase and phosphodiesterase activities in the dimorphic fungus Mucor rouxii.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Epstein.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
We have investigated the effect of Epstein-Barr virus nuclear antigen 1 (EBNA-1), a nuclear protein encoded by EBV, on herpes simplex virus type 1 (HSV-1) infection either in cells constitutively expressing EBNA-1 or in transient expression assays. Rat-1 cells and rat embryo fibroblasts (REF) immortalized by c-myc or E1A were transfected with a specific EBV DNA fragment coding for EBNA-1. Cloned cell lines which constitutively expressed this antigen were infected with HSV-1. Our results indicate that in EBNA-1-expressing cells, virus growth was higher than in control cells for different virus strains or rodent cell lines. This increase was maximal when cells were infected at low multiplicity, as determined by virus growth, and correlated with the stimulation of viral DNA synthesis. REF + c-myc and Vero cells were cotransfected by an EBNA-1 expression vector driven by Moloney murine leukaemia virus LTR and HSV-1 immediate-early (alpha 0) or early thymidine kinase upstream promoter regulatory regions linked to chloramphenicol acetyltransferase (CAT) coding sequences as effectors. In both cell lines, stimulation of CAT expression by EBNA-1 was observed only with the immediate-early promoter. These results suggest that EBNA-1 can transactivate immediate-early HSV-1 expression.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Choice of the earmold for a particular individual is perhaps the most subjective of all decisions made by clinicians in hearing aid fitting. The four earmold designs used in this study were standard-long, standard-short, belled-vented, and cavernous. Conslusions were: 1) performance differences in earmolds of contrasting design can be assessed by discrimination scores with monosyllabic word lists of equal difficulty; 2) among the physical measures taken of the earmold-receiver systems, frequency-response overall range (HAIC) ranked the devices in agreement with group responses to a word identification task; and 3) these data offer a basis for endorsement of the standard-long and cavernous-short earmold types over the other two with their superiority evident in each of the discrimination categories of excellent, good, and poor.
Questions that involve willingness to risk or give up life often are used to measure the values of health states. In the Boston Health Study, interviews with 291 patients who had AIDS included questions about health status and current desire for resuscitation, and a series of hypothetical questions about desire for life-extending efforts if the patients found themselves in undesirable states, such as being chronically nauseous or blind. An index, "reluctance to give up life" was made from five such questions. The desire for resuscitation was related to current health status, but the general reluctance to give up life was not. Desire to be resuscitated was significantly related to current health status only when "reluctance to give up life" was "low." For people reluctant to say they will give up any life at all, questions that involve risking or trading life seem likely to be poor measures of the values of health states.
Explore the source record for details and available documents.
To determine who provides gynecologic care for women who see internists, we interviewed 474 women who had return appointments at an academic primary care internal medicine center (PCC). Interview data indicated that 241 patients (51 percent) received gynecologic care in the PCC, 145 patients (31 percent) received gynecologic care from a non-PCC source, 48 patients (10 percent) did not receive needed care, and 40 patients (8 percent) did not require gynecologic care. Among the 145 patients who received gynecologic care from a non-PCC source, 121 (83 percent) received routine services that were readily available in the PCC. After completion of the interview, 28 (23 percent) of these 121 patients indicated that they did not plan to return to their non-PCC gynecologic provider. An economic analysis revealed that the savings to the patients and their insurers that could be realized by providing gynecologic care in the PCC for patients who were willing to switch from a non-PCC source would nearly offset the cost of providing routine gynecologic care to those patients who are in need of such care but are not now receiving it. Because internists are being trained to provide most routine gynecologic services, they often should be able to save their patients the cost and inconvenience of an extra visit to another physician.